Skip to main content
Log in

Saccharomyces cerevisiae strain UFMG 905 protects against bacterial translocation, preserves gut barrier integrity and stimulates the immune system in a murine intestinal obstruction model

  • Original Paper
  • Published:
Archives of Microbiology Aims and scope Submit manuscript

Abstract

Probiotic is a preparation containing microorganisms that confers beneficial effect to the host. This work assessed whether oral treatment with viable or heat-killed yeast Saccharomyces cerevisiae strain UFMG 905 prevents bacterial translocation (BT), intestinal barrier integrity, and stimulates the immunity, in a murine intestinal obstruction (IO) model. Four groups of mice were used: mice undergoing only laparotomy (CTL), undergoing intestinal obstruction (IO) and undergoing intestinal obstruction after previous treatment with viable or heat-killed yeast. BT, determined as uptake of 99mTc-E. coli in blood, mesenteric lymph nodes, liver, spleen and lungs, was significantly higher in IO group than in CTL group. Treatments with both yeasts reduced BT in blood and all organs investigated. The treatment with both yeasts also reduced intestinal permeability as determined by blood uptake of 99mTc-DTPA. Immunological data demonstrated that both treatments were able to significantly increase IL-10 levels, but only viable yeast had the same effect on sIgA levels. Intestinal lesions were more severe in IO group when compared to CTL and yeasts groups. Concluding, both viable and heat-killed cells of yeast prevent BT, probably by immunomodulation and by maintaining gut barrier integrity. Only the stimulation of IgA production seems to depend on the yeast viability.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

References

  • Akin ML, Uluutku H, Erenglu C, Ilicak EN, Elbuken E, Erdemoglu A, Celenk T (2002) Hyperbaric oxygen ameliorates bacterial translocation in rats with mechanical intestinal obstruction. Dis Colon Rectum 45:967–972

    Article  PubMed  Google Scholar 

  • Aldemir M, Kökoglu OF, Geyik MF, Büyükbayram H (2002) Effects of octreotideacetate and Saccharomyces boulardii on bacterial translocation in an experimental intestinal loop obstruction model of rats. Tohoku J Exp Med 198:1–9

    Article  CAS  PubMed  Google Scholar 

  • Buts JP, de Keyser N (2006) Effects of Saccharomyces boulardii on intestinal mucosa. Dig Dis Sci 51:1485–1492

    Article  PubMed  Google Scholar 

  • Chang TMC, Lu RH, Tsai LM (2001) Glutamine ameliorates mechanical obstruction-induced intestinal injury. J Surg Res 95:133–140

    Article  CAS  PubMed  Google Scholar 

  • Ciriello CJ, Lachance MA (2001) YEASTCOMPARE. University of Western Ontario, London

    Google Scholar 

  • Czerucka D, Rampal P (2002) Experimental effects of Saccharomyces boulardii on diarrheal pathogens. Microbes Infect 4:733–739

    Article  PubMed  Google Scholar 

  • Dalmasso D, Loubat A, Dahan S, Calle G, Rampal P, Czerucka D (2006) Saccharomyces boulardii prevents TNF-α induced apoptosis in EHEC-infected T84 cells. Res Microbiol 55:1–10

    Google Scholar 

  • Deitch EA (2002) Bacterial translocation or lymphatic drainage of toxic products from the gut: what is important in human beings? Surgery 131:241–244

    Article  PubMed  Google Scholar 

  • Diniz ASOF, Resende BM, Nunan EA, Simal CJR, Cardoso VN (1999) 99mTechnetium labelled Escherichia coli. Appl Rad Isot 51:33–36

    Article  CAS  Google Scholar 

  • FAO/WHO Report (2002) Food and Agricultural Organization/World Health Organization Working Group. Guidelines for the evaluation of probiotics in food, London, Ontario, Canada, April 30 and May 1

  • Fietto JLR, Araújo RS, Valadão FN, Fietto LG, Brandão RL, Neves MJ, Gomes CO, Nicoli JR, Castro IM (2004) Molecular and physiological comparisons between Saccharomyces cerevisiae and Saccharomyces boulardii. Can J Microbiol 50:615–621

    Article  CAS  PubMed  Google Scholar 

  • Gatt M, Reddy BS, Macfie J (2007) Review article: bacterial translocation in the critically ill evidence and methods of prevention. Aliment Pharmacol 25:741–757

    Article  CAS  Google Scholar 

  • Gedek BR (1999) Adherence of Escherichia coli serogroup O 157 and the Salmonella typhimurium mutant DT 104 to the surface of Saccharomyces boulardii. Mycoses 42:261–264

    Article  CAS  PubMed  Google Scholar 

  • Geyik MF, Aldemir M, Hosoglu S, Ayaz C, Satilmis S, Buyukbayram H, Kokoglu OF (2006) The effects of Saccharomyces boulardii on bacterial translocation in rats with obstruction jaundice. Ann Rev Coll Surg Engl 88:178–180

    Google Scholar 

  • Grimbaldeston M, Nakae S, Kalesnikoff J, Tsai M, Galli SJ (2007) Mast cell-derived interleukin 10 limits skin pathology in contact dermatitis and chronic irradiation with ultraviolet B. Nat Immunol 8:1095–1104

    Article  CAS  PubMed  Google Scholar 

  • Hajishengallis G, Nikolova E, Russel MW (1992) Inhibition of Streptococcus mutans adherence to saliva-coated hydroxyapatite by human secretory immunoglobulin A antibodies to the cell surface protein antigen I/II: reversal by IgA 1 protease cleavage. Infect Immun 60:5057–5064

    CAS  PubMed  Google Scholar 

  • Herek O, Kara IG, Kaleli I (2004) Effects of antibiotics and Saccharomyces boulardii on bacterial translocation in burn injury. Surg Today 34:256–260

    Article  CAS  PubMed  Google Scholar 

  • Imaoka A, Shima T, Kato K, Mizuno S, Uehara T, Matsumoto S, Hara ST, Umesaki Y (2008) Anti-inflammatory activity of probiotic Bifidobacterium: enhancement of IL-10 production in peripheral blood mononuclear cells from ulcerative colitis patients and inhibition of IL-8 secretion in HT-29 cells. World J Gastroenterol 16:2511–2516

    Article  CAS  Google Scholar 

  • Jorgensen B, Keller A, Radvanska E, Rittig S, Taagehoj-Jensen F, Frokiaer J, Jorgensen T, Pedersen M (2006) Reproducibility of contrast enhanced magnetic resonance renography in adolescents. J Urol 176:1171–1176

    Article  PubMed  Google Scholar 

  • Kataria J, Li N, Wynn JL, Neu J (2009) Probiotic microbes: do they need to be alive to be beneficial? Nutr Rev 67:546–550

    Article  PubMed  Google Scholar 

  • Kumura H, Tanoue Y, Tsukahara M, Tanaka T, Shimazaki K (2004) Screening of dairy yeast strains for probiotic applications. J Dairy Sci 87:4050–4056

    Article  CAS  PubMed  Google Scholar 

  • Li N, Russell WM, Douglas-Escobar M, Hauser N, Lopez M, Neu J (2009) Live and heat-killed Lactobacillus rhamnosus GG: effects on pro-inflammatory and anti-inflammatory cytokines/chemokines in gastrostomy-fed infant rats. Pediatr Res 66:203–207

    Article  CAS  PubMed  Google Scholar 

  • Lichtman SM (2001) Bacterial translocation in humans. J Pediatr Gastroenterol Nutr 33:1–10

    Article  CAS  PubMed  Google Scholar 

  • Martins FS, Nardi RMD, Arantes RME, Rosa CA, Neves MJ, Nicoli JR (2005) Screening of yeast as probiotic based on capacities to colonize the gastrointestinal tract and to protect against enteropathogen challenge in mice. J Gen Appl Microbiol 51:83–92

    Article  CAS  PubMed  Google Scholar 

  • Martins FS, Rodrigues ACP, Tiago FCP, Penna FJ, Rosa CA, Arantes RME, Nardi RMD, Neves MJ, Nicoli JR (2007) Saccharomyces cerevisiae strain 905 reduces the translocation of Salmonella enterica serotype Typhimurium and stimulates the immune system in gnotobiotic and conventional mice. J Med Microbiol 56:352–359

    Article  CAS  PubMed  Google Scholar 

  • Martins FS, Silva AA, Vieira AT, Barbosa FHF, Arantes RME, Teixeira MM, Nicoli JR (2009) Comparative study of Bifidobacterium animalis, Escherichia coli, Lactobacillus casei and Saccharomyces boulardii probiotic properties. Arch Microbiol 191:623–630

    Article  CAS  PubMed  Google Scholar 

  • Miyauchi E, Morita H, Tanabe S (2009) Lactobacillus rhamnosus alleviates intestinal barrier dysfunction in part by increasing expression of zonula occludens-1 and myosin light-chain kinase in vivo. J Dairy Sci 92:2400–2408

    Article  CAS  PubMed  Google Scholar 

  • National Research Council (1996) Guide for the care and use of laboratory animals. National Academy Press, Washington

    Google Scholar 

  • Oliveira MA, Lemos DL, Diniz ASOF, Coelho J, Cardoso VN (2006) Prevention of bacterial translocation using glutamine: a new strategy of investigation. Nutrition 22:419–424

    Article  PubMed  CAS  Google Scholar 

  • Quirino IEP, Correia MITD, Cardoso VN (2007) The impact of arginine on bacterial translocation in an intestinal obstruction model in rats. Clin Nutr 26:335–340

    Article  CAS  PubMed  Google Scholar 

  • Sun Z, Wang X, Deng X, Lasson A, Wallén R, Hallberg E, Andersson R (1998) The influence of intestinal ischemia and reperfusion on bidirectional intestinal barrier permeability, cellular membrane integrity, proteinase inhibitors, and cell death in rats. Shock 10:203–212

    Article  CAS  PubMed  Google Scholar 

  • Surawicz CM (2003) Probiotics, antibiotic-associated diarrhoea and Clostridium difficile diarrhoea in humans. Best Pract Res Clin Gastroenterol 17:775–783

    Article  PubMed  Google Scholar 

  • Tannock G (2005) Probiotics and prebiotics: scientific aspects, 1st edn. Caister Academic Press, University of Otago, Dunedin

    Google Scholar 

  • Tiago FCP, Martins FS, Rosa CA, Nardi RMD, Cara DC, Nicoli JR (2009) Physiological characterization of non-Saccharomyces yeasts from agro-industrial and environmental origins with possible probiotic function. World J Microbiol Biotechnol 25:657–666

    Article  Google Scholar 

  • Viana M, Santos R, Generoso S, Arantes R, Correia M, Cardoso V (2009) Pretreatment with arginine preserves intestinal barrier integrity and reduces bacterial translocation in mice. Nutrition 26:218–233

    Article  PubMed  CAS  Google Scholar 

  • Wiest R, Rath HC (2003) Bacterial translocation in the gut. Best Pract Res Clin Gastroenterol 17:397–425

    Article  PubMed  Google Scholar 

Download references

Acknowledgments

The study was supported by grants from Fundação de Amparo à Pesquisa do Estado de Minas Gerais (FAPEMIG) and Conselho Nacional de Pesquisa (CNPq). The authors thank Dr. Carlos A. Rosa for providing the yeast S. cerevisiae 905.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Valbert N. Cardoso.

Additional information

Communicated by Erko Stackebrandt.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Generoso, S.V., Viana, M., Santos, R. et al. Saccharomyces cerevisiae strain UFMG 905 protects against bacterial translocation, preserves gut barrier integrity and stimulates the immune system in a murine intestinal obstruction model. Arch Microbiol 192, 477–484 (2010). https://doi.org/10.1007/s00203-010-0574-8

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00203-010-0574-8

Keywords

Navigation